TR
Trinity Biotech plc
TRIB · NASDAQ
$9.41 -0.95% (-$0.09)
1M -24.30%
Market Cap $9.72M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$13.04
38.6% upside
Trenutna cena
$9.41
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica TRIB trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.22x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 11.10%
EPS growth N/A
FCF growth N/A
Profitability
14 /100
Weak Gross margin 35.40%
Net margin 85.32%
FCF margin 14.46%
Quality
7 /100
Poor ROIC 15.14%
ROA 35.59%
Asset turnover 0.42x
Debt
0 /100
High Current ratio 0.25x
Int. coverage -0.53x
Debt/Equity N/A
Stability
61 /100
Moderate Beta 0.97x
Rev. volatility 18.49%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TRIB
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
John Gillard
Employees
287
Headquarters
Bray
Prihajajoči dogodki
10 DEC.
Earnings
Upcoming earnings report